首页> 外文期刊>Surgical Endoscopy >Feasibility of transanal minimally invasive surgery for mid-rectal lesions
【24h】

Feasibility of transanal minimally invasive surgery for mid-rectal lesions

机译:经肛门微创手术治疗直肠中段病变的可行性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Transanal minimally invasive surgery (TAMIS) has emerged as an alternative to transanal endoscopic microsurgery. We assessed the feasibility of TAMIS for lesions located in the mid rectum. Methods: From July 2010 to October 2011, 16 consecutive patients with rectal pathology underwent TAMIS. After a single-incision laparoscopic surgery port was introduced into the anal canal, pneumorectum was established with a laparoscopic device, followed by transanal excision with conventional laparoscopic instruments, including graspers, monopolar electrocautery, and needle drivers. Clinicopathological findings, surgical procedure results, and perioperative outcomes were determined prospectively. Results: Of the 16 patients, 11 had rectal cancers (3 T1 lesions and 8 after preoperative chemoradiotherapy), 4 had neuroendocrine tumors, and 1 had a mucocele. The median length of the lesions from anal verge was 7.5 cm (range 4-10 cm). All procedures were completed laparoscopically without conversion to conventional transanal approach. The median operating time was 86 min (range 33-160 min), and the median estimated blood loss was 15 ml (range 0-150 ml) with no patient requiring intraoperative transfusions. There was no surgical morbidity or mortality, but one patient died during follow-up due to synchronous advanced gastric cancer. The median postoperative hospital stay was 3 days (range 2-6 days). Conclusions: TAMIS seems to be a feasible and safe treatment option for lesions located in the mid rectum.
机译:背景:经肛门微创手术(TAMIS)已成为经肛门内镜显微手术的替代方法。我们评估了TAMIS治疗直肠中部病变的可行性。方法:2010年7月至2011年10月,连续16例直肠病理学患者接受TAMIS。将单切口腹腔镜手术口引入肛管后,用腹腔镜装置建立肺脏肿瘤,然后用常规腹腔镜仪器经肛门切除,包括抓紧器,单极电灼和针头驱动器。前瞻性确定临床病理结果,手术结果和围手术期结果。结果:16例患者中,直肠癌11例(T1病变3例,术前放化疗8例),神经内分泌肿瘤4例,黏液囊肿1例。肛门边缘病变的中位长度为7.5 cm(范围4-10 cm)。所有手术均在腹腔镜下完成,无需转换为常规经肛门入路。中位手术时间为86分钟(范围为33-160分钟),中位估计失血量为15毫升(范围为0-150毫升),无患者需要术中输血。没有手术发病率或死亡率,但是有一名患者在随访期间因同步晚期胃癌死亡。术后中位住院时间为3天(范围2-6天)。结论:TAMIS似乎是直肠中部病变的一种可行且安全的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号